Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Clinical Pharmacology In The Elderly: Prospective Evaluation Of The Pharmacokinetics, Pharmacogenetics And Pharmacodynamics Of CPT-11 And Aging

Authors not listed

Alliance for Clinical Trials in Oncology · 2001

Abstract

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Aging may affect the way these drugs work. PURPOSE: Phase I trial to determine the relationship between aging and the effectiveness of irinotecan in treating patients who have solid tumors.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-11 MST

Cite this

APA
Anonymous. (2001). Clinical Pharmacology In The Elderly: Prospective Evaluation Of The Pharmacokinetics, Pharmacogenetics And Pharmacodynamics Of CPT-11 And Aging. <em>Alliance for Clinical Trials in Oncology</em>. https://clinicaltrials.gov/study/NCT00026195
Vancouver
Anonymous. Clinical Pharmacology In The Elderly: Prospective Evaluation Of The Pharmacokinetics, Pharmacogenetics And Pharmacodynamics Of CPT-11 And Aging. Alliance for Clinical Trials in Oncology. 2001.
BibTeX
@misc{anon2001Clinic, title = {Clinical Pharmacology In The Elderly: Prospective Evaluation Of The Pharmacokinetics, Pharmacogenetics And Pharmacodynamics Of CPT-11 And Aging}, author = {Anonymous}, journal = {Alliance for Clinical Trials in Oncology}, year = {2001}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings